Business Context and Reporting Period
Company: Raymond James Financial, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended June 29, 2001.
Business Overview: The Company operates as a financial services firm with segments in retail distribution, institutional distribution, investment banking, and asset management. Operations span the U.S., Canada, Europe, and joint ventures in India, France, Turkey, and Argentina.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended June 29, 2001 |
9 Months Ended June 29, 2001 |
|---|---|---|
| Total Revenues | $421,992 | $1,278,019 |
| Net Income | $28,930 | $83,776 |
| Diluted EPS | $0.59 | $1.71 |
| Cash and Cash Equivalents | $392,963 | $392,963 (Balance Sheet) |
| Net Cash from Operating Activities | N/A | $834,687 |
| Loans Payable | $194,329 | $194,329 (Balance Sheet) |
| Shareholders' Equity | $765,672 | $765,672 (Balance Sheet) |
Assets Under Management (AUM): Total financial assets under discretionary management were $17.22 billion as of June 29, 2001, essentially flat compared to the prior year.
Material Changes vs. Prior Period
- Revenue: Quarterly revenues declined 1% to $422.0 million compared to $426.4 million in the prior year quarter. Nine-month revenues increased 1% to $1.28 billion. Excluding the acquired Canadian subsidiary (RJ Ltd.), revenues declined 3% year-over-year.
- Net Income: Quarterly net income increased 25% to $28.9 million ($0.59 diluted EPS) from $23.2 million ($0.50 diluted EPS). This increase was significantly driven by a $15.8 million pretax reversal of a legal reserve related to the Corporex settlement. Excluding this reversal and the prior year's $20 million charge, adjusted earnings declined significantly.
- Segment Performance:
- Investment Banking: Revenues increased 67% quarterly, driven by increased underwriting activity and the inclusion of RJ Ltd.
- Retail Distribution: Revenues declined 6% quarterly, reflecting poor equity markets and reduced retail investor activity.
- Net Interest Income: Declined 18% quarterly due to lower interest spreads as customer cash balances (lower yield) replaced margin loans (higher yield).
- Acquisition: The Company acquired Goepel McDermid Inc. (renamed Raymond James Ltd.) on January 1, 2001, for $78 million plus deferred compensation. This acquisition contributed $25.6 million in revenues for the quarter.
Guidance, Outlook, Risks, and Unusual Items
- Unusual Items (Corporex Settlement): The Company settled a $40.7 million judgment with Corporex Companies for $27.5 million. The current quarter included a $15.8 million pretax credit from the reversal of the remaining reserve. The prior year quarter included a $20 million pretax charge to increase the reserve.
- Market Conditions: Management notes that continued poor equity markets have negatively impacted retail trading volumes and commission revenues. However, underwriting activity picked up modestly toward the end of the quarter.
- Accounting Changes: The Company anticipates adopting SFAS No. 142 (Goodwill and Other Intangible Assets) for fiscal 2002, which will require goodwill to be reviewed for impairment rather than amortized. Approximately $63 million of unamortized goodwill will be subject to this transition.
- Liquidity and Capital: The Company maintains strong liquidity with $393 million in cash and cash equivalents. Net capital requirements for U.S. and Canadian broker-dealer subsidiaries are in compliance. The parent company has a $50 million term loan and a $125 million committed line of credit.
- Dividends: The Board increased the annual dividend to $0.36 per share (20% increase) in November 2000. Quarterly dividends of $0.09 were paid in the current period.
Investor Verification Checklist
- Adjusted Earnings: Verify the Company's "adjusted" earnings figures by excluding the $15.8 million Corporex reversal to understand core operational performance, which showed a decline.
- Acquisition Impact: Assess the contribution of the new Canadian subsidiary (RJ Ltd.) to revenue and expense growth to isolate organic performance trends.
- Interest Rate Sensitivity: Review the impact of the shift from margin loans to cash balances on net interest income, as this trend may persist in a low-interest-rate environment.
- Goodwill Impairment Risk: Monitor the upcoming adoption of SFAS 142 and the potential for transitional impairment losses on the $63 million goodwill balance.
- Legal Contingencies: Confirm the finality of the Corporex settlement and review the status of other pending litigation mentioned in the notes.